Claudia Pasqualini

8PUBLICATIONS
33CO-AUTHORS
Haematological tumoursAutonomic nervous systemPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Neonatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 04, 2025
Chemo-Immunotherapy Rescue for High-Risk Neuroblastoma Patients With Progressive Disease Before High-Dose Chemotherapy: Real-World Data From the SACHA-France Study.

Claudia Pasqualini, Stéphanie Proust, Gudrun Schleiermacher

|Sep 04, 2025
Atypical Neuroblastoma With Absent Urinary Catecholamine Excretion and 123ImIBG Avidity Are of Favorable Outcome: A Retrospective French Single-Center Study.

Anna Borovkov, Juliette Assy, Isabelle Aerts

|Aug 19, 2025
Neuroblastoma in Infants: Long-Term Survival From INES Protocols A SIOPEN Study.

Julie Savagner, Caroline Munzer, Gudrun Schleiermacher

|Oct 15, 2024
Rationale for irradiation of persisting oligo-skeletal metastases to improve survival of metastatic neuroblastoma patients with a poor response to chemotherapy: A retrospective study.

Lea Rossillon, Véronique Edeline, Laurentiu Agrigoroaie

|Dec 01, 2022
Number of lymph nodes sampled in SFCE/SIOP 2001 patients with Wilms tumour: Is the goal of more than six achievable?

Sabine Irtan, Aurore Coulomb-Lhermine, Camille Lanz

|Nov 23, 2021
High-dose chemotherapy followed by autologous stem cell rescue in Wilms tumors: French report on toxicity and efficacy.

Manon Delafoy, Arnauld Verschuur, Gudrun Scheleirmacher

Pageof 2

Frequent Collaborators

3 joint publications

Anne-Sophie Defachelles

3 joint publications

Gudrun Schleiermacher

2 joint publications

Hélène Sudour-Bonnange

2 joint publications

Pablo Berlanga